Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression

Prostate cancer is a heterogeneous disease. MiR-375 is a marker for prostate cancer progression, but its cellular function is not characterized. Here, we provide the first comprehensive investigation of miR-375 in prostate cancer. We show that miR-375 is enriched in prostate cancer compared to norma...

Descripción completa

Detalles Bibliográficos
Autores principales: Pickl, Julia M.A., Tichy, Diana, Kuryshev, Vladimir Y., Tolstov, Yanis, Falkenstein, Michael, Schüler, Julia, Reidenbach, Daniel, Hotz-Wagenblatt, Agnes, Kristiansen, Glen, Roth, Wilfried, Hadaschik, Boris, Hohenfellner, Markus, Duensing, Stefan, Heckmann, Doreen, Sültmann, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312160/
https://www.ncbi.nlm.nih.gov/pubmed/27449098
http://dx.doi.org/10.18632/oncotarget.10729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312160/
https://www.ncbi.nlm.nih.gov/pubmed/27449098
http://dx.doi.org/10.18632/oncotarget.10729

Ejemplares similares